| Dr Joseph Raymond Fiesel, PHARMD | |
|
6560 E State St, T-0810, Rockford, IL 61108-2545 | |
| (815) 227-9777 | |
| (815) 227-9777 |
| Full Name | Dr Joseph Raymond Fiesel |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 6560 E State St, Rockford, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780970988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 051292031 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Raymond Fiesel, PHARMD 6560 E State St, Rockford, IL 61108-2545 Ph: (815) 227-9777 | Dr Joseph Raymond Fiesel, PHARMD 6560 E State St, T-0810, Rockford, IL 61108-2545 Ph: (815) 227-9777 |
News Archive
The cost of treating men for heart disease topped $47 billion in 2008, leading a list of the 10 most expensive conditions for men age 18 and older, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The Washington Times examines how the U.S. Millennium Challenge Corporation, which dispenses U.S. foreign aid "meant to help reduce global poverty by stimulating economic growth," deals with countries that initially pass screening tests, but are later suspected of corruption.
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
Exercise therapy also improved the mood of MS patients in exercise therapy programs, compared to patients who did not participate in the therapy. The researchers did not find any evidence that exercise therapy affected patients' fatigue or their sense of how ill they were.
The risk and impact of cardiovascular adverse events in long-term users of tyrosine kinase inhibitors for chronic myeloid leukaemia is highlighted in a review published in the Journal of Clinical Oncology.
› Verified 5 days ago
Dr. Khareemat Oyindamola George, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2404 S Perryville Rd, Rockford, IL 61108 Phone: 815-332-3256 | |
Mr. James Michael Horvath, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 816 Featherstone Rd, Rockford, IL 61107 Phone: 815-227-0081 Fax: 815-387-5316 | |
Dr. Jon Suyko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3535 N Bell School Rd, Rockford, IL 61114 Phone: 779-696-9418 Fax: 779-696-9424 | |
Michelle Renee Day, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2642 Charles St, Rockford, IL 61108 Phone: 815-484-2461 Fax: 815-484-2462 | |
Rina Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5690 E State St, Rockford, IL 61108 Phone: 815-395-1828 | |
Steven F Zielinski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 W State St, Rockford, IL 61102 Phone: 815-490-1661 Fax: 915-963-4629 | |
Dr. Laura Ann Dee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3929 N Mulford Road, Rockford, IL 61114 Phone: 815-633-1318 |